Natural Fragrance and Allergen Labels: Evidence

Natural fragrance ingredients are attracting investment at the same moment that European cosmetic labels are becoming more specific about allergens. That pairing matters: a more sophisticated supply chain can broaden creative options, but it does not make every natural extract harmless or every sustainability claim independently proven.

On 22 September 2026, Symrise announced the opening of a Lautier 1795 production site in the Grasse region. The company says the site brings sourcing, transformation, innovation and perfumery expertise closer together and connects the recently acquired Floral Concept business with its wider fragrance network.

Why this is a market signal

The announcement is credible evidence that a major ingredients group is allocating capital to premium natural fragrance materials. It also points to industry demand for shorter development loops, specialist processing and closer relationships between growers, extractors, perfumers and brand customers.

What it does not prove is just as important. The release provides no independently audited life-cycle comparison, no quantified traceability rate, no biodiversity outcome and no like-for-like safety advantage over synthetic ingredients. Claims about resilience, quality and sustainability therefore remain company claims rather than completed independent findings.

The label rules changed

The European Commission says Regulation (EU) 2023/1545 added individual labelling requirements for 56 additional fragrance allergens. Since 31 July 2026, newly placed non-compliant cosmetic products may no longer enter the EU market; products already placed on the market before that date may continue to be made available until 31 July 2028.

Covered allergens must appear individually in the ingredient list above 0.001% in leave-on products and 0.01% in rinse-off products. Those thresholds are labelling triggers, not a guarantee that every person below them will be symptom-free and not a declaration that every product above them is unsafe.

Natural does not mean allergen-free

The SCCS scientific opinion identified established contact allergens among both individual chemicals and natural extracts. Botanical origin therefore cannot replace ingredient-level assessment: oxidation, harvest conditions, extraction method and storage can all affect the mixture to which skin is exposed.

A multicentre patch-test study involving 1,701 patients helps show how fragrance allergens can be investigated in people with suspected contact allergy. Its clinic-based population cannot be used as a general-population prevalence estimate, and patch testing belongs in appropriate clinical care rather than do-it-yourself experimentation.

Like-for-like evidence check

Symrise’s newsroom release answers whether the site opened and what business capabilities the company intends to combine. EU law and Commission guidance answer what must be labelled and when. The SCCS opinion and peer-reviewed study address sensitisation and contact-allergy evidence; none of these sources alone proves that the new facility produces safer or more sustainable finished perfumes.

This distinction keeps commercial news separate from scientific judgement. A natural extract may offer desirable odour complexity and sourcing stories, while a synthetic molecule may offer consistency or lower pressure on a scarce botanical; the correct comparison depends on the specific material, dose, use pattern, sourcing and verified environmental data.

Evidence level and limitations

LCY Evidence Meter: B overall. The site opening and regulatory dates are supported by primary corporate and regulatory sources, while the safety framing is supported by an SCCS opinion and peer-reviewed human data. The grade is not A because the company’s performance, traceability and sustainability claims lack independent comparative metrics in the cited announcement.

Important unknowns include plant capacity, batch-level traceability coverage, energy and water intensity, agricultural impacts, supplier-audit results and finished-product exposure. This article therefore treats the opening as a commercial and supply-chain signal, not proof of a superior consumer-health outcome.

Safety note

Seeing an allergen name on a label does not mean the product is dangerous for everyone. Individual labelling is especially useful for people already sensitised to a substance; persistent itching, redness or eczema should prompt discontinuation and advice from a qualified healthcare professional.

This article is educational and is not medical advice. It does not diagnose fragrance allergy, recommend home patch testing or replace a product safety assessment for a specific formula and use.

Commercial relationship disclosure

LifeCareYou has no declared sponsorship or affiliate relationship with Symrise, Lautier 1795 or Floral Concept. The facility, capacity and traceability narrative comes from Symrise’s own newsroom and is clearly separated here from independent regulatory and scientific evidence.